首页> 外文期刊>Brazilian Journal of Cardiovascular Surgery >Off-pump versus On-pump Coronary Artery Bypass Grafting in Frail Patients: Study Protocol for the FRAGILE Multicenter Randomized Controlled Trial
【24h】

Off-pump versus On-pump Coronary Artery Bypass Grafting in Frail Patients: Study Protocol for the FRAGILE Multicenter Randomized Controlled Trial

机译:体弱患者的非体外循环与体外循环冠状动脉旁路移植术:FRAGILE多中心随机对照试验的研究方案

获取原文
       

摘要

Abstract Introduction: Advances in modern medicine have led to people living longer and healthier lives. Frailty is an emerging concept in medicine yet to be explored as a risk factor in cardiac surgery. When it comes to CABG surgery, randomized controlled clinical trials have primarily focused on low-risk (ROOBY, CORONARY), elevated-risk (GOPCABE) or high-risk patients (BBS), but not on frail patients. Therefore, we believe that off-pump CABG could be an important technique in patients with limited functional capacity to respond to surgical stress. In this study, the authors introduce the new national, multicenter, randomized, controlled trial "FRAGILE", to be developed in the main cardiac surgery centers of Brazil, to clarify the potential benefit of off-pump CABG in frail patients. Methods: FRAGILE is a two-arm, parallel-group, multicentre, individually randomized (1:1) controlled trial which will enroll 630 patients with blinded outcome assessment (at 30 days, 6 months, 1 year, 2 years and 3 years), which aims to compare adverse cardiac and cerebrovascular events after off-pump versus on-pump CABG in pre-frail and frail patients. Primary outcomes will be all-cause mortality, acute myocardial infarction, cardiac arrest with successful resuscitation, low cardiac output syndrome/cardiogenic shock, stroke, and coronary reintervention. Secondary outcomes will be major adverse cardiac and cerebrovascular events, operative time, mechanical ventilation time, hyperdynamic shock, new onset of atrial fibrillation, renal replacement therapy, reoperation for bleeding, pneumonia, length of stay in intensive care unit, length of stay in hospital, number of units of blood transfused, graft patency, rate of complete revascularization, neurobehavioral outcomes after cardiac surgery, quality of life after cardiac surgery and costs. Discussion: FRAGILE trial will determine whether off-pump CABG is superior to conventional on-pump CABG in the surgical treatment of pre-frail and frail patients. Trial registration: ClinicalTrials.gov, ID: NCT02338947. Registered on August 29th 2014; last updated on March 21st 2016.
机译:摘要简介:现代医学的进步导致人们的寿命更长,更健康。脆弱是医学上的一个新兴概念,尚待探讨作为心脏手术的危险因素。对于CABG手术,随机对照临床试验主要针对低危患者(ROOBY,CORONARY),高危患者(GOPCABE)或高危患者(BBS),而不是体弱患者。因此,我们认为非体外循环CABG可能是功能有限的对手术压力作出反应的患者的一项重要技术。在这项研究中,作者介绍了一项新的全国性,多中心,随机,对照试验“ FRAGILE”,该试验将在巴西的主要心脏外科手术中心进行开发,以阐明无泵CABG对体弱患者的潜在益处。方法:FRAGILE是一项两组平行,多组,多中心,单独随机(1:1)对照试验,将对630名患者进行盲法评估(30天,6个月,1年,2年和3年)。 ,该研究的目的是比较体弱多病的患者和体弱者在体外循环和体外循环CABG后心脏和脑血管不良事件。主要结果将是全因死亡率,急性心肌梗塞,成功复苏后的心脏骤停,低心输出量综合征/心源性休克,中风和冠状动脉再介入。次要结果将是主要的不良心脏和脑血管事件,手术时间,机械通气时间,高动力性休克,新发房颤,肾脏替代疗法,再次手术出血,肺炎,重症监护病房住院时间,住院时间,输血单位数,移植物通畅率,完全血运重建率,心脏手术后的神经行为预后,心脏手术后的生活质量和费用。讨论:FRAGILE试验将确定在脆弱和脆弱患者的手术治疗中,非体外循环CABG是否优于传统的体外循环CABG。试验注册:ClinicalTrials.gov,ID:NCT02338947。 2014年8月29日注册;最后更新时间为2016年3月21日。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号